Children with primary combined immunodeficiency (CID) and human cytomegalovirus (HCMV) infection often deteriorate despite antiviral therapy. In this study, the emergence of ganciclovirresistant strains was examined in 6 children with CID and HCMV infection, using sequence analysis of the HCMV UL97 gene and virus susceptibility assays. Mutations in the proposed ATP binding site associated with ganciclovir resistance were found in 4 of the 6 children. In 1 patient with B 0 severe CID, an unusual multiplicity of mutations was found in the UL97 substrate binding domain between aa 590 -606. All mutations were detected within 10 days to 3 weeks from initiation of therapy. The emergence of resistant strains in children with CID appears earlier than in other groups of HCMV-infected patients. These findings may have relevance to the cellular pathways involved in viral DNA repair and mutagenesis, and they indicate the need for early and frequent genotypic monitoring and prompt therapeutic modification in this patient population.
Human cytomegalovirus (HCMV) is a major pathogen in ciclovir resistance in HCMV strains from children with CID. We report the early emergence of ganciclovir-resistant strains children with primary combined immunodeficiency disorders (CID) [1] . These children are increasingly treated by allogeneic in CID patients who have received ganciclovir following BMT. bone marrow transplantation (BMT) but remain susceptible to severe HCMV infection and disease even after successful Materials and Methods hematopoietic reconstitution.
Patients and clinical specimens. Plasma specimens and
Ganciclovir is widely used for the treatment and prophylaxis HCMV isolates recovered from 6 children with primary CID disorof HCMV disease in immunocompromised persons [2] . Howders and HCMV infection were studied. These patients were ever, prolonged ganciclovir therapy can lead to the developtreated at two BMT centers between 1995 and 1997 and constituted ment of ganciclovir-resistant HCMV strains. Ganciclovir-resis- 54 .5% of the patients with primary CID treated at the 2 centers tant strains have been recovered mainly from adult AIDS during the study period. All 6 patients were evaluated for ganpatients who have received the drug for ú3 months, and occaciclovir resistance because of persistent disease activity accompasionally, it has been recovered from transplant patients [3 -6] . In this study, we used direct genotypic analysis to determine cousins, who had received BMT from the same donor. These patients had primary HCMV infection, which was most likely the presence of UL97 gene mutations associated with ganacquired from the donor who exhibited seroconversion after transplantation. Patients 1, 4, and 6 were HCMV seropositive before transplantation (for patients 4 and 6, the donor was also sero- tively. The same mutation was also detected in consecutive ) encompassing the putative substrate binding site.
plasma specimens from patient 2. gB gene analysis confirmed PCR products, which were visualized as single and clear bands, the presence of the same genotype in patients 2 and 3.
were resolved by gel electrophoresis and purified from low-melt-A ganciclovir-resistant leukocyte isolate recovered from paing-point agarose gel. The purified PCR products were subjected tient 4 contained mixed wild-type and mutant UL97 sequences to direct PCR sequencing, using the fmol DNA sequencing system in both methionine 460 and the putative substrate binding site confirmed by automated DNA sequencing (ABI PRISM 377; Results Perkin-Elmer ABI, Foster City, CA) using a fluorescent dye terminator cycle. Mutations were detected after 3 days of ganSix children with primary CID who were treated with ganciclovir for HCMV disease were examined for the presence of ciclovir therapy; however, the patient had received ganciclovir / 9d4c$$au49 07-01-98 22:03:35 jinfa UC: J Infect for 3 weeks, 2 months previously (total 24 days). In contrast to-Phe or Leu-to-Ser substitution), 591 -594 deletion, and 603 (Cys-to-Trp substitution) in ganciclovir activation and resisto the multiple mixed UL97 sequences, gB analysis revealed the presence of a single genotype in the isolate and plasma of tance has been confirmed using marker transfer experiments [4, 5, 7, 12] . patient 4.
For patients 5 and 6, who excreted ganciclovir-sensitive Mutations between aa 596 and 607 have also been reported wild-type strains, gB analysis identified the presence of 2 disin ganciclovir-resistant clinical isolates. However, the impact tinct genotypes in the BAL and urine in patient 5 and a single of the single substitutions identified at aa 596 -599 and 606 genotype in the plasma and leukocyte isolate in patient 6.
remains to be directly established. The coexistence of mutations Ultimately, all 4 patients who excreted ganciclovir-resistant clustered in proximity in a ganciclovir-resistant strain of a mutant strains died with clinical and histologic evidence of single gB genotype suggests that this larger region could funcsevere HCMV disease. Of the 2 patients who excreted gantion in drug recognition and binding and in clinical ganciclovir ciclovir-sensitive strains, 1 died of HCMV pneumonia, and resistance. the other recovered following therapy, with resolution of the Antiviral drug resistance may arise from production of novel cultures and PCR signals.
mutations during therapy or from selection of mutant virus populations already present before therapy. In AIDS patients, the presence of ganciclovir-resistance mutations correlates with Discussion longer duration of therapy, usually exceeding 3 months [3 -5, 13] . Of interest, mutations in children with CID were already Herein, we describe the appearance of HCMV strains with detected after 10 days to 3 weeks of ganciclovir therapy. This UL97 gene mutations associated with ganciclovir resistance in early temporal pattern suggests rapid selection of pretherapy 4 children with primary CID. All 4 patients excreted strains resistant strains. This is further supported by the concurrent with mutations in the methionine 460, which is located in the excretion of the same mutant variant in the 2 children who proposed ATP binding site of the UL97 phosphotransferase.
acquired HCMV infection from the same donor. The detected mutations included the well-known Met-to-Val
It is important to note that all 4 patients who developed substitution, which has been shown to confer ganciclovir resisresistant strains had received haploidentical T cell -depleted tance in HCMV laboratory and clinical strains [4, 5, 8, 11] , BMT. Hence, the major contributing factor appears to be the and a Met-to-Leu substitution, which has not been documented profound immunosuppression associated with the underlying previously. In 1 patient, additional mutations were detected in disease (combined with delayed immune reconstitution followthe carboxy-terminal region of the gene between aa 590 and 606. The role of aa 594 (Ala-to-Val substitution), 595 (Leuing bone marrow ablation and T cell depletion) and the associ-
